InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by Moxham Christopher, Directeur Scientifique. Officer active across 1 company, notably Fulcrum Therapeutics, Inc.. Cumulatively, 1 reports have been published. History available since 10 August 2021. The latest transaction was filed on 10 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Moxham Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
20,714 shares@ US$7.84100.0% of flowCommon StockSEC:0000899243-21-032755:0
1 of 1 declaration
About Moxham Christopher
Christopher Moxham is the Chief Scientific Officer at Fulcrum Therapeutics, Inc. He is responsible for scientific direction and innovation within the company. His role is essential in developing new treatments and therapeutic solutions.
